Overhaul for Intercell as new CEO takes over
This article was originally published in Scrip
Executive Summary
The setback-ridden Austrian vaccine developer Intercell has unveiled Thomas Lingelbach, who has been chief operating officer since 2006, as its new CEO after Gerd Zettlmeissl resigned "to pursue other personal and professional interests".